Patient Guide: To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 63 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06072131
Status: 🟢 Enrolling Now
Condition: Peripheral T Cell Lymphoma
Phase: PHASE3

Where You Can Participate

This study is available at 63 locations across the country.

Top locations include:
  • • Clovis, California
  • • Santa Monica, California
  • • Pembroke Pines, Florida
  • • And 60 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL - Join Clinical Trial NCTNCT06072131

How to Join This Clinical Trial - NCTNCT06072131

Learn how to participate in this PHASE3 trial studying an investigational therapy for Peripheral T Cell Lymphoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Peripheral T Cell Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Peripheral T Cell Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06072131 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 63 locations. Find a study site near you:

Clinical Research Site

Clovis, California 93611 - United States

Status: RECRUITING

Clinical Research Site

Santa Monica, California 90404 - United States

Status: RECRUITING

Clinical Research Site

Pembroke Pines, Florida 33026 - United States

Status: RECRUITING

Clinical Research Site

Louisville, Kentucky 40207 - United States

Status: RECRUITING

Clinical Research Site

New Brunswick, New Jersey 08901 - United States

Status: RECRUITING

Clinical Research Site

Harlingen, Texas 78550 - United States

Status: WITHDRAWN

Clinical Research Site

Houston, Texas 77030 - United States

Status: RECRUITING

Clinical Research Site

Houston, Texas 77030 - United States

Status: RECRUITING

Clinical Research Site

Temple, Texas 76508 - United States

Status: RECRUITING

Clinical Research Site

Ottawa, Ontario K1H 8L6 - Canada

Status: RECRUITING

And 53 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Peripheral T Cell Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships